Literature DB >> 1588463

Cryptococcosis in cats: clinical and mycological assessment of 29 cases and evaluation of treatment using orally administered fluconazole.

R Malik1, D I Wigney, D B Muir, D J Gregory, D N Love.   

Abstract

Twenty-nine cats with naturally occurring cryptococcosis were evaluated prior to commencing oral fluconazole therapy (25-100 mg every 12 h). Affected cats ranged from 2 to 15 years-of-age. Male cats (19; 66%) and Siamese cats (5; 21%) appeared to be over-represented in comparison to the hospital's cat population. Mycotic rhinitis was observed in 24 (83%) of the cases, although nasal cavity involvement was subtle in four animals. Disease of the skin and subcutaneous tissues was present in 15 cases (52%) and amongst these the nasal plane (seven cats) and bridge of the nose (seven cats) were most commonly involved. Primary infection of the central nervous system was not encountered, although one cat developed meningoencephalitis and optic neuritis as a sequel to longstanding nasal cavity disease. Antibodies against the feline immunodeficiency virus (FIV) were detected in eight cats (28%), and these cats tended to have advanced and/or disseminated disease. There was a tendency for cats to develop cryptococcosis during the Australian summer. Organisms were cultured from 27 cases. Cryptococcus neoformans var. neoformans was isolated from 21 cats, while C. neoformans var. gattii was identified in the remaining six. The response to oral fluconazole was excellent in this series, which included many cats with advanced, longstanding or disseminated disease. The fungal infection resolved in all but one advanced case which died after only 4 days of therapy. A dose of 50 mg per cat, given every 12 h, produced a consistently good response without side effects. Lower doses were effective in some cases, while 100 mg every 12 h was required to control the infection in one cat. Serum fluconazole levels obtained during chronic dosing (50 +/- 18 mg l-1, mean +/- SD; 50 mg per cat every 12 h) were highly variable (range 15-80 mg l-1). Concurrent FIV infection did not impart an unfavourable prognosis, although affected cats often required prolonged courses of therapy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1588463     DOI: 10.1080/02681219280000181

Source DB:  PubMed          Journal:  J Med Vet Mycol        ISSN: 0268-1218


  27 in total

1.  Temperature-sensitive strain of Cryptococcus neoformans producing hyphal elements in a feline nasal granuloma.

Authors:  D A Bemis; D J Krahwinkel; L A Bowman; P Mondon; K J Kwon-Chung
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Acute hind limb paralysis secondary to an extradural spinal cord Cryptococcus gattii lesion in a dog.

Authors:  Lindsey Kurach; Chris Wojnarowicz; Tom Wilkinson; Colin Sereda
Journal:  Can Vet J       Date:  2013-05       Impact factor: 1.008

3.  Natural environmental sources of Cryptococcus neoformans var. gattii.

Authors:  T C Sorrell; A G Brownlee; P Ruma; R Malik; T J Pfeiffer; D H Ellis
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

4.  Cranial vena cava syndrome secondary to cryptococcal mediastinal granuloma in a cat.

Authors:  Jo-Annie Letendre; Søren Boysen
Journal:  Can Vet J       Date:  2015-04       Impact factor: 1.008

Review 5.  Cryptococcus gattii infections.

Authors:  Sharon C-A Chen; Wieland Meyer; Tania C Sorrell
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

Review 6.  Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans.

Authors:  T G Mitchell; J R Perfect
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

7.  Clinical characteristics and predictors of mortality for Cryptococcus gattii infection in dogs and cats of southwestern British Columbia.

Authors:  Colleen Duncan; Craig Stephen; John Campbell
Journal:  Can Vet J       Date:  2006-10       Impact factor: 1.008

8.  Contribution of the mannan backbone of cryptococcal glucuronoxylomannan and a glycolytic enzyme of Staphylococcus aureus to contact-mediated killing of Cryptococcus neoformans.

Authors:  Reiko Ikeda; Fumito Saito; Miki Matsuo; Kenji Kurokawa; Kazuhisa Sekimizu; Masashi Yamaguchi; Susumu Kawamoto
Journal:  J Bacteriol       Date:  2007-05-04       Impact factor: 3.490

9.  Feline nasal granuloma due to Cryptoccocus gattii type VGII.

Authors:  Pedro Henrique Magalhães Cardoso; Francisco de Assis Baroni; Eriques Gonçalves Silva; Diana Costa Nascimento; Marilena Dos Anjos Martins; Walderez Szezs; Claudete Rodrigues Paula
Journal:  Mycopathologia       Date:  2013-08-13       Impact factor: 2.574

10.  Investigation in Central Italy of the possible association between Cryptococcus neoformans var. Gattii and Eucalyptus camaldulensis.

Authors:  E Campisi; F Mancianti; G Pini; E Faggi; G Gargani
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.